NCT00222495View on ClinicalTrials.gov

A Comparative Study of New Medications for Psychosis in Adolescents

NACompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

August 31, 2006

Conditions

Psychotic DisordersSchizophreniaSchizophreniform DisordersSchizoaffective Disorders

Interventions

DRUG

quetiapine

DRUG

olanzapine

DRUG

risperidone

Trial Locations (1)

55454

University of Minnesota Medical Center, Minneapolis

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

collaborator

Jensen, Jonathan B., M.D.

INDIV

lead

University of Minnesota

OTHER